EPS Outperformer Should Set New High Today

Written by GSCR Staff   
Tuesday, 09 July 2013 22:56

In a recent edition of The Goldman Guide we mentioned that trading on news will remain one way to ‘seek alpha’ in the market this summer.  Another earnings season is upon us, driving upward momentum in stocks that beat Street estimates, such as today's profiled stock, which should set a new high today.

Yesterday, after the market closed, Franklin Covey Company (NYSE – FC - $14.50) announced 3Q13 earnings.  The news was awesome, so look for a nice pop in the short-term.  Revenue for 3Q13 was $44.9 million actual versus $43.3 estimate, and EPS was $0.13 per share versus the $0.12 estimate for the same period.  Revenue was up over 11% from last quarter and EPS was up from $0.08 per share from last quarter as well.

Franklin Covey is somewhat of a corporate America ‘household’ name with the Franklin Planner products, something you would be familiar with if you entered the workforce sometime before the late 1990’s and the advent of scheduling systems on web-based and other software solutions.  The Company has kept with the times, so to speak, and offers a wide variety of products to address leadership, execution, productivity, trust, customer loyalty, sales performance, and education problems worldwide. FC also offers clients training in management skills, relationship skills, and individual effectiveness, as well as personal-effectiveness literature and electronic educational solutions. In addition, it sells a suite of individual-effectiveness and leadership-development training products; and books, e-books, audio media, downloadable and paper-based tools, content-rich software applications for smart phones and other handheld devices, training accessories, and other related products.

Recently, FC landed two major deals for its The Leader in Me and The 7 Habits of Highly Effective People products in China and the Netherlands.  These deals should provide an additional revenue stream for the Company.

The charts indicate a bullish signal for the short-term including a very bullish signal on the favorite EMA.  With earnings forecast at $0.62 and $0.88 per share for 2013 and 2014 respectively, a shift in P/E makes the stock attractive as the trailing 12-month P/E is 29.1 moves to a forward 12-month P/E of 16.4 from a valuation standpoint.  We think a price target of $18 over the next few months is a strong possibility.

Have a great day.

Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.

Disclaimer:

This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm’s internally generated stock ideas while the Opportunity product reflects sponsored research reports. 

It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations. 

The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.

This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.

ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS   INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.

For more information, visit our Disclaimer: www.goldmanresearch.com

Add comment
  • No comments found